New Indication Approved for Juv éderm New Indication Approved for Juv éderm

In a randomized, controlled trial, 59% of adults reported experiencing at least one treatment site response.Medscape Medical News

Source: Medscape Dermatology Headlines - March 6, 2024 Category: Dermatology Tags: Dermatology Source Type: news